Announcements

With gratitude for Dr. Lisenbee's many years of service, leadership, and dedication to cancer care and research

Beloved DCI member Dawn Tranchino Provenzale, MD, a professor of Medicine in the Division of Gastroenterology, has passed away.

Erin Wood, Senior IT Analyst, Duke Cancer Institute Information Systems, honored with a Duke Presidential Award.

Neelima Navuluri, MD, MPH, receives NCCN Foundation Young Investigator Award for her project to improve lung cancer screening among Black Veterans.

Scott Balderson, PA-C, shares why he’s excited for his new role as president of the Association of Physician Assistants in Cardiothoracic and Vascular Surgery.

Neeraj Agrawal, MD, has accepted the role of director of Medical Oncology for Duke Cancer Institute in Wake County, effective March 15.

In the age of Covid, Community Outreach & Engagement at DCI comes of age, team expands with disparities researcher/associate director

The NCCN has published new best practice recommendations for Management of COVID-19 Infection in Patients with Cancer. Related event on March 20.

Beloved Duke Cancer Institute member Dina Randazzo, DO, assistant professor of Neurosurgery and Neurology, has passed away.

DCI, with 130 cancer centers & orgs, signed letter urging Biden admin. & U.S. states to continue prioritizing cancer patients, survivors in COVID-19 vaccine rollout.

Nobel laureate and DCI member Robert Lefkowitz’ first memoir, “A Funny Thing Happened on the Way to Stockholm,” was published this month.

Susan Dent, MD, co-director of the Duke Cardio-Oncology Program, is a leading international expert in the field. She is also associate director of Clinical Research in DCI's Breast Program.

In an open letter, the NCCN, ACS, and major U.S. cancer centers, inc. DCI, urge public to resume cancer screening & treatment during pandemic.

DCI director Michael B. Kastan, MD, PhD, announced a planned reconfiguration of DCI’s NCI-Designated Research Programs and welcomed new research leaders.

Kevin Oeffinger, MD, is guest co-editor of a new book covering colorectal, lung, cervical, prostate, skin cancer, and ovarian cancer screening.

Ken Young, MD, PhD, will assume the role of chief, Hematopathology Division and DCI Blood Cancer Pathology Service, on Jan. 1, 2021.

Duke Radiology, in the Duke SoM, recently launched the Duke Center for Artificial Intelligence in Radiology.

Brent Hanks, MD, PhD, was named associate director of Translational Science for the Melanoma Disease Group this month.

NCI welcomes the Duke BioRepository & Precision Pathology Center as the new site of the Southern Division of the Cooperative Human Tissue Network.

Monica Cfarku RN, MSN, BMTCN, CCM, NE-BC, has been named Assistant Vice President and Chief of Oncology Nursing Services for the Duke Cancer Institute.

NEW FROM DUKE HEALTH: Comprehensive virtual tour of Duke Health facilities, new med student/fellow/resident recruitment resources, and updated SoM facts & figures.

The Duke Cancer Center Durham and Duke Women’s Cancer Care Raleigh boutiques now open by appointment for in-person shopping, self-image consultations.

For a second year, Arif Kamal, MD, MHS, MBA, FAAHPM, FASCO, has been named an ASCO Advocacy Champion.

DCI medical oncologist Robin Hardie-Hood, MD, division chief of Medical Oncology at DRH, named medical director, Duke Cancer Center North Durham.

Duke Cancer Institute welcomes a new medical oncologist specializing in the treatment of breast cancer. He will practice at two of DCI's Wake County locations.

Join us with your “Don’t Ever Give Up!” spirit to ride any distance, any time and any place throughout August.

Duke Cancer Institute continues to ensure that patients have access to the safest and best-quality care possible.

A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at DCI is part of an effective, two-drug strategy for enlisting the immune system to fight tumors.

Radiation oncologist Joseph Kamel Salama, MD, named to the 2020 class of ASTRO Fellows.

From her family to yours: Duke ortho oncology surgeon Julia Visgauss, MD, invites one and all to this year's virtual event, to be held Sept. 12/13.

The Duke University SoM to expand into a newly-leased research center in RTP. Includes DHVI, CIVICS, Dept. of Surgery, Dept. of Medicine, Immunology, Pediatrics.

Nolan Miller, MHA, has been named administrative director, team lead, effective July 13. This is a newly created role within DCI.

Duke Cancer Institute welcomes a new clinical investigator specializing in bladder cancer to its Genitourinary Oncology program.

A message from President Price and Chancellor Washington on Duke Becoming a Tobacco-Free Campus.

NCCN released new Guidelines for Patients in it's Immunotherapy Side Effects series, with the publication of a book focused on CAR T-Cell therapy.

NCCN announced the publication of new Guidelines for Patients in the Immunotherapy Side Effects series with the publication of a book on Immune Checkpoint Inhibitors.

Flags were lowered to half-staff today across Duke for Neil Spector, MD, physician-scientist, mentor, advocate, friend, husband, and father who passed away on June 14.

 Yvonne Mowery, MD, PhD, was one of four young physician-scientists nationwide selected to receive the Damon Runyon Clinical Investigator Award.

On Monday, June 1, Caring House re-opened after having been closed temporarily due to COVID-19 precautions.

Duke Cancer Institute will present more than 100 abstracts across multiple cancer types during the ASCO20 Virtual Scientific Program of the 2020 ASCO Annual Meeting.

This is of substantial significance to the department and university because it marks the funding of a new national center.

Twelve faculty in the School of Medicine were recently awarded distinguished professorships. A third of these are DCI members.

Duke Cancer Institute member and family physician Kevin Oeffinger, MD, has been named a Fellow of the American Society of Clinical Oncology (FASCO). 

Christopher Kelsey, MD, associate professor in the Department of Radiation Oncology and DCI member, was awarded the 2020 Algernon Sydney Sullivan Award.

The National Cancer Institute has created new pages on its website related to the rapidly evolving COVID-19 situation: one for patients and one for researchers.

The DCRI study is the first cardiovascular outcomes trial to compare two different types of cancer treatment.

The LLS COVID-19 Patient Financial Aid Program will provide $250 to eligible blood cancer patients experiencing financial hardship due to the pandemic.

PCORI has funded up to $50 million to evaluate hydroxychloroquine as a preventive drug for the novel coronavirus.

Duke Health research and clinical teams have confirmed a way to use existing vaporized hydrogen peroxide methods to decontaminate the masks.

The clinical trial of a potential COVID-19 therapy gives hospitalized adult patients with significant symptoms an option to participate.